Digital Diagnostic News Today

Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a

Healthcare

With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.

Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a retinal camera. It makes quick diagnoses, without a doctor present.

Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.

/PRNewswire/ -- Digital Diagnostics – a leading AI diagnostics company on a mission to transform global healthcare – has rebranded its flagship product, the AI...

/PRNewswire/ -- Digital Diagnostics – maker of IDx-DR, the first-ever FDA-cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy –...

Eyenuk, a company that makes technology for eye screenings, raised $26 million in a Series A funding round, bringing its total funding to more than $43 million. Research shows that the company's AI system is more accurate in detecting diabetic retinopathy than a clinical examination from a general ophthalmologist or a retina specialist.

/PRNewswire/ -- OSF Ventures, the investment arm of OSF HealthCare, has joined a $75 million Series B financing round to support Iowa-based Digital...

/PRNewswire/ -- Today, Digital Diagnostics – creator of IDx-DR, the first-ever FDA De Novo cleared, fully autonomous AI system for the diagnosis of diabetic...